Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Ando

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|July 5, 2002
ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipaseTetsuya Shimizugawa, Mitsuru Ono, Mitsuru Shimamura, et al.
The Journal of Toxicological Sciences|October 9, 2010
Circadian modulation of hepatic transcriptome in transgenic rats expressing human growth hormoneJun Hirao, Noriyo Niino, Shingo Arakawa, et al.
In Vivo (Athens, Greece)|October 29, 2022
Early Palliative Care Improves Overall Survival in Patients With Lymphoma: A Single-institution Retrospective StudyMisaki Morisaku, Kaori Ito, Tatsuki Shimomura, et al.
Biological & Pharmaceutical Bulletin|June 24, 2021
The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib TreatmentSeira Nishibe-Toyosato, Yosuke Ando, Yasuhiro Goto, et al.
International Journal of Clinical Oncology|June 4, 2025
Impact of cancer type differences on chemotherapy-induced nausea and vomiting (CINV) incidence in oxaliplatin-based regimens for gastric and colorectal cancer: a retrospective studyNanaho Hiraga, Yosuke Ando, Hiroshi Matsuoka, et al.
Biological & Pharmaceutical Bulletin|March 1, 2023
Factors Affecting the Comprehension of Outpatients Receiving Cancer ChemotherapySeira Nishibe-Toyosato, Yosuke Ando, Nayu Nakasuji, et al.
In Vivo (Athens, Greece)|February 28, 2024
Effect of Liver Dysfunction on S-1 Therapy Induced Adverse Effects: A Retrospective Cohort StudyYosuke Ando, Yuki Shibata, Takuma Ishihara, et al.
Japanese Journal of Clinical Oncology|July 8, 2025
Comparison of standard and biweekly trifluridine/tipiracil plus bevacizumab regimens in advanced or recurrent colorectal cancer: a retrospective studyYosuke Ando, Hiroshi Matsuoka, Hanaho Orito, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2006
Characterization of phenotypes in Gstm1-null mice by cytosolic and in vivo metabolic studies using 1,2-dichloro-4-nitrobenzeneKazunori Fujimoto, Shingo Arakawa, Yukari Shibaya, et al.
Oncology|September 30, 2016
Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell LymphomaKaori Ito, Masataka Okamoto, Yoko Inaguma, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|July 5, 2002
ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipaseTetsuya Shimizugawa, Mitsuru Ono, Mitsuru Shimamura, et al.
The Journal of Toxicological Sciences|October 9, 2010
Circadian modulation of hepatic transcriptome in transgenic rats expressing human growth hormoneJun Hirao, Noriyo Niino, Shingo Arakawa, et al.
In Vivo (Athens, Greece)|October 29, 2022
Early Palliative Care Improves Overall Survival in Patients With Lymphoma: A Single-institution Retrospective StudyMisaki Morisaku, Kaori Ito, Tatsuki Shimomura, et al.
Biological & Pharmaceutical Bulletin|June 24, 2021
The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib TreatmentSeira Nishibe-Toyosato, Yosuke Ando, Yasuhiro Goto, et al.
International Journal of Clinical Oncology|June 4, 2025
Impact of cancer type differences on chemotherapy-induced nausea and vomiting (CINV) incidence in oxaliplatin-based regimens for gastric and colorectal cancer: a retrospective studyNanaho Hiraga, Yosuke Ando, Hiroshi Matsuoka, et al.
Biological & Pharmaceutical Bulletin|March 1, 2023
Factors Affecting the Comprehension of Outpatients Receiving Cancer ChemotherapySeira Nishibe-Toyosato, Yosuke Ando, Nayu Nakasuji, et al.
In Vivo (Athens, Greece)|February 28, 2024
Effect of Liver Dysfunction on S-1 Therapy Induced Adverse Effects: A Retrospective Cohort StudyYosuke Ando, Yuki Shibata, Takuma Ishihara, et al.
Japanese Journal of Clinical Oncology|July 8, 2025
Comparison of standard and biweekly trifluridine/tipiracil plus bevacizumab regimens in advanced or recurrent colorectal cancer: a retrospective studyYosuke Ando, Hiroshi Matsuoka, Hanaho Orito, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2006
Characterization of phenotypes in Gstm1-null mice by cytosolic and in vivo metabolic studies using 1,2-dichloro-4-nitrobenzeneKazunori Fujimoto, Shingo Arakawa, Yukari Shibaya, et al.
Oncology|September 30, 2016
Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell LymphomaKaori Ito, Masataka Okamoto, Yoko Inaguma, et al.
Pageof 6